Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Fortis Healthcare Ltd. ( (IN:FORTIS) ) has provided an announcement.
Fortis Healthcare Limited has announced a significant acquisition of shares in its subsidiary Agilus Diagnostics Limited, increasing its stake to 89.2%. This strategic move involved purchasing shares from private equity investors NYLIM Jacob Ballas India Fund III, LLC and Resurgence PE Investments Limited, as well as previously acquired shares from the International Finance Corporation. The acquisitions are part of a broader strategy to consolidate its holdings in the diagnostics sector, which may enhance Fortis’s market position and influence in the field. The completion of these transactions is expected by January 20, 2025.
More about Fortis Healthcare Ltd.
Fortis Healthcare Limited operates in the healthcare industry, providing a range of healthcare services. Through its subsidiary, Agilus Diagnostics Limited, Fortis offers diagnostic services. The company has a significant presence in the Indian market, with a focus on expanding its diagnostics services.
YTD Price Performance: -8.06%
Average Trading Volume: 49,806
Current Market Cap: 501B INR
For detailed information about FORTIS stock, go to TipRanks’ Stock Analysis page.